SLC38A4
Basic information
Region (hg38): 12:46764761-46832408
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC38A4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 16 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 2 | 1 |
Variants in SLC38A4
This is a list of pathogenic ClinVar variants found in the SLC38A4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-46766725-A-T | not specified | Uncertain significance (Jun 17, 2024) | ||
12-46766756-A-G | not specified | Uncertain significance (Apr 15, 2024) | ||
12-46766759-C-G | not specified | Uncertain significance (Oct 19, 2024) | ||
12-46768314-A-G | not specified | Uncertain significance (Nov 25, 2024) | ||
12-46768329-C-G | not specified | Uncertain significance (Oct 25, 2022) | ||
12-46769332-C-T | not specified | Uncertain significance (Nov 20, 2023) | ||
12-46769333-A-C | not specified | Uncertain significance (Sep 12, 2024) | ||
12-46769388-G-C | not specified | Uncertain significance (Aug 12, 2022) | ||
12-46769413-T-G | not specified | Uncertain significance (Oct 26, 2022) | ||
12-46775108-T-C | not specified | Uncertain significance (Nov 20, 2023) | ||
12-46775135-C-T | not specified | Uncertain significance (Jul 30, 2024) | ||
12-46775165-C-T | not specified | Uncertain significance (Nov 09, 2024) | ||
12-46776979-C-T | not specified | Uncertain significance (Jun 29, 2022) | ||
12-46776996-C-T | not specified | Likely benign (Mar 07, 2023) | ||
12-46778506-A-G | not specified | Uncertain significance (Mar 26, 2024) | ||
12-46778539-C-T | not specified | Uncertain significance (Dec 16, 2023) | ||
12-46778547-T-G | not specified | Uncertain significance (Sep 11, 2024) | ||
12-46778571-T-C | not specified | Likely benign (Feb 27, 2023) | ||
12-46778607-C-T | not specified | Uncertain significance (Apr 26, 2024) | ||
12-46778649-T-A | not specified | Uncertain significance (Sep 17, 2021) | ||
12-46778662-A-C | not specified | Uncertain significance (Mar 19, 2024) | ||
12-46784569-C-A | not specified | Uncertain significance (Aug 16, 2021) | ||
12-46788026-G-A | Benign (Mar 29, 2018) | |||
12-46788529-T-A | not specified | Uncertain significance (Sep 22, 2023) | ||
12-46788532-T-A | not specified | Uncertain significance (Oct 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC38A4 | protein_coding | protein_coding | ENST00000447411 | 15 | 67646 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.560 | 0.440 | 125660 | 0 | 7 | 125667 | 0.0000279 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.50 | 225 | 298 | 0.755 | 0.0000147 | 3588 |
Missense in Polyphen | 64 | 114.09 | 0.56098 | 1368 | ||
Synonymous | 0.758 | 93 | 103 | 0.905 | 0.00000513 | 1041 |
Loss of Function | 3.92 | 6 | 28.7 | 0.209 | 0.00000150 | 355 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000127 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000665 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Sodium-dependent amino acid transporter. Mediates electrogenic symport of neutral amino acids and sodium ions. Has a broad specificity, with a preference for Ala, followed by His, Cys, Asn, Ser, Gly, Val, Thr, Gln and Met. May mediate sodium- independent transport of cationic amino acids, such as Arg and Lys. Amino acid uptake is pH-dependent, with low transport activities at pH 6.5, intermediate at pH 7.0 and highest between pH 7.5 and 8.5. {ECO:0000269|PubMed:11342143, ECO:0000269|PubMed:11414754}.;
- Pathway
- Polythiazide Action Pathway;Methyclothiazide Action Pathway;Bumetanide Action Pathway;Spironolactone Action Pathway;Eplerenone Action Pathway;Triamterene Action Pathway;Amiloride Action Pathway;Ethacrynic Acid Action Pathway;Quinethazone Action Pathway;Bendroflumethiazide Action Pathway;Glucose-Alanine Cycle;Chlorthalidone Action Pathway;Trichlormethiazide Action Pathway;Iminoglycinuria;Lysinuric Protein Intolerance;Blue diaper syndrome;Lysinuric protein intolerance (LPI);Cystinuria;Indapamide Action Pathway;Furosemide Action Pathway;Torsemide Action Pathway;Hartnup Disorder;Glucose Transporter Defect (SGLT2);Kidney Function;Glucose Transporter Defect (SGLT2);Metolazone Action Pathway;Hydrochlorothiazide Action Pathway;Cyclothiazide Action Pathway;Hydroflumethiazide Action Pathway;Chlorothiazide Action Pathway;Biopterin metabolism;Amino acid transport across the plasma membrane;Amino acid and oligopeptide SLC transporters;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Lipoate metabolism;Histidine metabolism;Urea cycle and metabolism of arginine, proline, glutamate, aspartate and asparagine;Valine, leucine and isoleucine degradation;Aminosugars metabolism;Bile acid biosynthesis;Glycerophospholipid metabolism;Porphyrin metabolism;Glycine, serine, alanine and threonine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.164
Intolerance Scores
- loftool
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.6
Haploinsufficiency Scores
- pHI
- 0.306
- hipred
- Y
- hipred_score
- 0.699
- ghis
- 0.394
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.230
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc38a4
- Phenotype
Gene ontology
- Biological process
- amino acid transmembrane transport;sodium ion transport;amino acid transport
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- amino acid transmembrane transporter activity;symporter activity